{
  "trial_id": "NCT03384407",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age \u226518 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Normal health status (as determined by the Investigator review of medical history and blood donor physical exam)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Weight over 140 lbs.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Complete blood count (CBC; including RBC indices MCV, MCH, MCHC, and RDW) and serum chemistry values within normal limits",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Minimum hemoglobin levels of 13 g/dL for female and 14 g/dL for male subjects",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Negative blood donor screening test panel for HIV, HBV, HCV, HTLV, Syphilis, WNV and Zika virus",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Female subjects of childbearing potential and male subjects must agree to use a medically acceptable method of contraception throughout the study periods",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Meet or exceed AABB guidelines for blood donation (with the exception of travel deferrals)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Signed and dated informed consent form",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Up to 12 subjects will be enrolled for a maximum of 6 eligible subjects in the pilot study",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Clinically significant acute or chronic disease (as determined by the Investigator)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "History of RBC autoantibodies/autoimmune hemolytic anemia, RBC alloantibodies or autoimmune disease",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "History of congenital red cell disorders including glucose-6-phosphate dehydrogenase (G6PD) deficiency",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Positive Direct (DAT) and Indirect antiglobulin test (IAT) at study entry",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Immunosuppressive therapy (e.g., oral or IV prednisone) within the past 28 days",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Treatment with any medication known to affect RBC viability",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Pregnant or nursing female",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Male subjects or female subjects of childbearing potential not using effective contraception",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "The patient is a 55 year old man with lower urinary tract symptoms. He has normal blood chemistry values and meets the inclusion criteria for age, health status, weight, CBC, serum chemistry, hemoglobin levels, and blood donor screening test panel.",
  "_meta": {
    "topic_id": "24",
    "trial_id": "NCT03384407",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}